Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes Journal:Clinical Infectious Diseases | 26-Aug-2023 | ||
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study Journal:The Lancet Gastroenterology & Hepatology | 1-Dec-2024 |